Achievements
-
.73mcourses of SP+AQ
were shipped to countries in West Africa's Sahel region in 2016, by MMV's partner Guilin Pharmaceutical, enough to provide 18 million children with Seasonal Malaria Chemoprevention
-
.>90%of severe malaria cases
now treated with injectable artesunate in preference to quinine across 6 countries through the MMV-led ISMO project
-
.MMV048progresses to phase IIa
as new formulation with 3x greater exposure identified
Defeating malaria together
Featured resources
-
A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria
Oct 2017 -
Treating malaria: new drugs for a new era
Sep 2017 -
Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
Aug 2017
